Spero Health has announced plans to open a new addiction treatment clinic in Findlay, Ohio to quickly respond to the growing need for outpatient community-based services as overdose deaths reach an all-time high. CARF-accredited, Spero Health is a national leader in providing care for individuals struggling with addiction and will bring affordable, high quality addiction treatment services through a combination of telehealth and in-person visit options at this new clinic. Located at 1645 Tiffin Avenue, the clinic will open its doors on February 17th, joining a network of over 45 Spero Health locations throughout Kentucky, Ohio, Tennessee, Virginia, and Indiana, providing care for more than 8,500 patients. Spero Health accepts Ohio Medicaid and most commercial insurance plans. Individuals who need addiction treatment services are encouraged to walk-in for help or call: 419-745-9852 for more information or to schedule an appointment.
According to Harm Reduction of Ohio, 2020 could mark one of the deadliest years for drug overdoses, which have occurred over a broad section of the state affecting both small and large cities, cutting into all demographics. The latest data from the Center for Disease Control reported more than 81,000 people died due to drug overdoses in the 12 months from May 2019 through May 2020, confirming the largest number of overdose deaths recorded in a single year.
Spero Health, Inc., is an integrated health care services organization specializing in local and affordable outpatient care for individuals suffering from substance use disorders with a mission to “Save Lives, Instill Hope, and Restore Relationships.” Spero Health utilizes an evidence-based integrated care model that combines both physical and behavioral health care services under one roof to treat the whole person. Its community-based approach to treatment allows consumers to continue working and caring for their families as they overcome addiction. Spero Health operates over 45 outpatient clinics located throughout Kentucky, Indiana, Virginia, and Tennessee.
This was reported by Spero Health on February 11, 2021.